Repurposing medications.
作者信息
Novack Gary D
机构信息
PharmaLogic Development Inc, San Rafael, CA, USA; Department of Ophthalmology & Visual Sciences, University of California, Davis, USA.
出版信息
Ocul Surf. 2021 Jan;19:336-340. doi: 10.1016/j.jtos.2020.11.012. Epub 2020 Nov 26.
Abstract
摘要
相似文献
1
Repurposing medications.药物再利用。
Ocul Surf. 2021 Jan;19:336-340. doi: 10.1016/j.jtos.2020.11.012. Epub 2020 Nov 26.
2
Repurposing strategies for tropical disease drug discovery.热带病药物研发的重新利用策略。
Bioorg Med Chem Lett. 2016 Jun 1;26(11):2569-76. doi: 10.1016/j.bmcl.2016.03.103. Epub 2016 Mar 30.
3
Repurposing Drugs: An Empowering Approach to Drug Discovery and Development.药物再利用：药物发现和开发的赋权方法。
Drug Res (Stuttg). 2023 Nov;73(9):481-490. doi: 10.1055/a-2095-0826. Epub 2023 Jul 21.
4
IUPHAR review - Data-driven computational drug repurposing approaches for opioid use disorder.IUPHAR 评论——用于阿片类药物使用障碍的数据驱动的计算药物再利用方法。
Pharmacol Res. 2024 Jan;199:106960. doi: 10.1016/j.phrs.2023.106960. Epub 2023 Oct 11.
5
Repurposing Marketed Drugs as Antidepressants with In Silico, In Vivo, and In Vitro Screening Methods.利用计算机筛选、体内试验和体外试验方法，将已上市药物重新用于抗抑郁治疗。
Adv Exp Med Biol. 2023;1423:271-278. doi: 10.1007/978-3-031-31978-5_27.
6
Adera2.0: A Drug Repurposing Workflow for Neuroimmunological Investigations Using Neural Networks.Adera2.0：使用神经网络进行神经免疫研究的药物再利用工作流程。
Molecules. 2022 Sep 30;27(19):6453. doi: 10.3390/molecules27196453.
7
Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.近期药物重定位驱动的新型抗生素发现进展。
Curr Med Chem. 2019;26(28):5363-5388. doi: 10.2174/0929867325666180706101404.
8
Drug repurposing: a promising tool to accelerate the drug discovery process.药物重定位：加速药物发现过程的有前途的工具。
Drug Discov Today. 2019 Oct;24(10):2076-2085. doi: 10.1016/j.drudis.2019.06.014. Epub 2019 Jun 22.
9
Revisiting Repurposing.重新审视重新利用
Assay Drug Dev Technol. 2016 Dec;14(10):554-556. doi: 10.1089/adt.2016.766.
10
Current approaches in identification of a novel drug targets for drug repurposing.当前鉴定新药靶标进行药物重定位的方法。
Prog Mol Biol Transl Sci. 2024;205:213-220. doi: 10.1016/bs.pmbts.2024.03.020. Epub 2024 Apr 4.
引用本文的文献
1
Repurposing the hypoglycaemic agents for neuroinflammation, a comprehensive review.将降血糖药物用于神经炎症的研究综述
3 Biotech. 2025 Sep;15(9):281. doi: 10.1007/s13205-025-04455-7. Epub 2025 Aug 5.
2
DrugReX: an explainable drug repurposing system powered by large language models and literature-based knowledge graph.DrugReX：一个由大语言模型和基于文献的知识图谱驱动的可解释药物再利用系统。
Res Sq. 2025 Jun 16:rs.3.rs-6728958. doi: 10.21203/rs.3.rs-6728958/v1.
3
Upcycling the anthracyclines: New mechanisms of action, toxicology, and pharmacology.升级利用蒽环类药物：新的作用机制、毒理学和药理学。
Toxicol Appl Pharmacol. 2023 Jan 15;459:116362. doi: 10.1016/j.taap.2022.116362. Epub 2022 Dec 30.
4
A Randomised Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Palovarotene Ophthalmic Solution.一项评估帕罗维诺特眼用溶液安全性、耐受性和药代动力学的随机 I 期研究。
Drugs R D. 2023 Mar;23(1):43-53. doi: 10.1007/s40268-022-00410-6. Epub 2022 Dec 21.
5
Applications of natural language processing in ophthalmology: present and future.自然语言处理在眼科中的应用：现状与未来。
Front Med (Lausanne). 2022 Aug 8;9:906554. doi: 10.3389/fmed.2022.906554. eCollection 2022.
6
Drug repurposing: a systematic review on root causes, barriers and facilitators.药物再利用：根源、障碍和促进因素的系统评价。
BMC Health Serv Res. 2022 Jul 29;22(1):970. doi: 10.1186/s12913-022-08272-z.
7
Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline.《中国眼科超说明书用药专家共识：临床诊疗指南》
Front Pharmacol. 2022 May 24;13:919688. doi: 10.3389/fphar.2022.919688. eCollection 2022.
8
Expedited regulatory product approval in the time of COVID-19.在新冠疫情期间加快监管产品审批
Ocul Surf. 2022 Oct;26:345-348. doi: 10.1016/j.jtos.2022.05.007. Epub 2022 May 28.
9
The Complex Structure of the Pharmacological Drug-Disease Network.药理药物-疾病网络的复杂结构
Entropy (Basel). 2021 Aug 31;23(9):1139. doi: 10.3390/e23091139.
10
Compounded medications for ocular surface disease.用于眼表疾病的复方药物。
Ocul Surf. 2021 Oct;22:267-270. doi: 10.1016/j.jtos.2021.09.004. Epub 2021 Sep 20.
本文引用的文献
1
Publication rate in preclinical research: a plea for preregistration.临床前研究中的发表率：呼吁进行预注册。
BMJ Open Sci. 2020 Aug 27;4(1):e100051. doi: 10.1136/bmjos-2019-100051. eCollection 2020.
2
Nature journals ink open-access deal.
Science. 2020 Oct 23;370(6515):391. doi: 10.1126/science.370.6515.391-a.
3
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.羟氯喹或联合阿奇霉素治疗轻中度 COVID-19。
N Engl J Med. 2020 Nov 19;383(21):2041-2052. doi: 10.1056/NEJMoa2019014. Epub 2020 Jul 23.
4
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
5
Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2.关于 SARS-CoV-2 的再定位药物和特效治疗药物的研究进展。
Future Med Chem. 2020 Sep;12(17):1565-1578. doi: 10.4155/fmc-2020-0158. Epub 2020 Jul 8.
6
Clinical Pharmacology Considerations for Developing Small-Molecule Treatments for COVID-19.开发小分子 COVID-19 治疗药物的临床药理学考虑因素。
J Clin Pharmacol. 2020 Sep;60(9):1147-1154. doi: 10.1002/jcph.1697. Epub 2020 Jul 12.
7
Investigate Oral Zinc as a Prophylactic Treatment for Those at Risk for COVID-19.研究口服锌对新冠病毒病高危人群的预防治疗作用。
Am J Ophthalmol. 2020 Aug;216:A5-A6. doi: 10.1016/j.ajo.2020.04.028. Epub 2020 May 26.
8
Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?秋水仙碱作为一种古老的抗炎药物，对新冠病毒肺炎是否有效？
J Clin Pharmacol. 2020 Jul;60(7):828-829. doi: 10.1002/jcph.1645. Epub 2020 May 23.
9
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
10
15 drugs being tested to treat COVID-19 and how they would work.15种正在进行新冠病毒治疗测试的药物及其作用原理。
Nat Med. 2020 May 15. doi: 10.1038/d41591-020-00019-9.
Zotero 插件